Beta Drugs Limited

NSE: BETA · Unclassified

₹1,805.90-1.89%06 Nov 2026

Ask the data

Instant answers about Beta Drugs Limited — computed from its filings, no language model

Market cap₹2,008 cr

Current price₹1,805.90

High / Low₹2,668 / ₹1,030

P/E221.9

P/B4.59

Book value₹393.6

ROE2.1%

ROCE17.0%

Debt / equity0.11

Dividend yield—

EPS (TTM)₹8.14

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY25	FY26
Revenue	362.4	384.8
EBITDA	74.6	75.7
Operating margin	20.6%	19.7%
Interest	7.0	15.3
Depreciation	12.5	17.1
Profit before tax	57.0	54.4
Tax	14.6	12.9
Net profit	42.4	41.5
EPS ₹	42.02	40.92
Operating cash flow	31.6	37.3
Capex	36.9	53.5
Dividend paid	0.0	0.0
Total assets	436.2	495.8
Equity	197.1	244.8

Quarterly performance

last 4 quarters · ₹ crore

	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	87.3	94.0	125.5	137.5
Operating profit	17.0	17.7	27.4	30.3
Operating margin	19.5%	18.8%	21.8%	22.0%
Other income	2.3	2.9	1.6	1.8
Interest	4.4	3.9	2.6	1.6
Depreciation	4.4	4.8	4.3	4.6
Profit before tax	10.5	11.8	22.0	25.8
Tax	1.9	2.8	5.6	6.5
Net profit	0.0	9.1	0.0	0.0
EPS ₹	8.40	8.93	14.78	16.59

Returns & margins

trailing-twelve-month, per quarter

	SEP '26
ROE	2.1%
ROCE	17.0%
Net margin	2.0%
EBITDA margin	20.8%
Debt / equity	0.11
Interest coverage	6.58
Asset turnover	0.68

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	10.1	10.1	10.1	11.1
Other equity / reserves	187.0	210.9	234.6	426.6
Total equity	197.1	221.0	244.8	437.7
Borrowings	132.7	145.8	147.8	48.7
Current liabilities	102.8	114.4	108.1	144.4
Non-current liabilities	136.4	152.4	142.9	37.2
Total assets	436.2	487.8	495.8	656.3
Property, plant & equipment	80.4	102.3	115.4	119.4
Capital work-in-progress	—	—	0.0	8.8
Investments	0.0	0.0	0.0	0.0
Inventories	59.8	73.0	74.5	81.9
Receivables	102.6	120.3	119.1	167.4
Cash & equivalents	0.2	0.1	124.8	0.5

Cash flow

annual · ₹ crore · line = free cash flow

	FY25	FY26
Cash from operations	31.6	37.3
Cash from investing	-35.7	-51.4
Cash from financing	117.9	-8.1
Capex	36.9	53.5
Free cash flow	-5.3	-16.2
Dividends paid	0.0	0.0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹119.4 cr18%

CWIP

₹8.8 cr1%

Inventories

₹81.9 cr12%

Receivables

₹167.4 cr26%

Cash & equivalents

₹0.5 cr0%

Other assets

₹278.4 cr42%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Beta Drugs Limited	2,008	1,805.90	221.9	4.59	2.1%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-9.3%

6 months+32.9%

1 year-4.8%

3Y CAGR+20.4%

5Y CAGR+24.1%

10Y CAGR—

50-day avg₹1,994.45

200-day avg₹1,725.71

RSI (14)51

FAQs

What is the share price of Beta Drugs Limited?

Beta Drugs Limited (BETA) closed at ₹1,805.90 on NSE on 06 Nov 2026.

What is the market cap of Beta Drugs Limited?

₹2,008 crore at the latest close.

What is the P/E ratio of Beta Drugs Limited?

221.9, on trailing-twelve-month earnings from its filings.

How fast is Beta Drugs Limited growing?

Not enough filed history yet to measure Beta Drugs Limited's growth.

How profitable is Beta Drugs Limited?

On a trailing-twelve-month basis return on equity is 2.1%, return on capital employed 17.0%, operating margin 20.8%, net margin 2.0%.

How much debt does Beta Drugs Limited have?

Beta Drugs Limited is lightly geared: debt to equity is 0.11 with borrowings of ₹49 cr against cash of ₹0 cr (balance sheet of 2026-09-30). Operating profit covers interest 6.6 times.

Financials parsed from Beta Drugs Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '25, annual from FY25, balance sheet from Mar '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.